CIK 1816307
SILVERARC CAPITAL MANAGEMENT, LLC
Institutional 13F holdings & portfolio
Holdings
68
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 51–68 of 68
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| TELA | TELA BIO INC | 2.6M | $1M+ | SH |
| QURE | UNIQURE NV | 126K | $1M+ | SH |
| TARS | TARSUS PHARMACEUTICALS INC | 36K | $1M+ | SH |
| KYMR | KYMERA THERAPEUTICS INC | 35K | $1M+ | SH |
| — | ULTRAGENYX PHARMACEUTICAL IN | 110K | $1M+ | SH (Call) |
| NXTC | NEXTCURE INC | 176K | $1M+ | SH |
| ELUT | ELUTIA INC | 2.8M | $1M+ | SH |
| SION | SIONNA THERAPEUTICS INC | 41K | $1M+ | SH |
| CTMX | CYTOMX THERAPEUTICS INC | 386K | $1M+ | SH |
| XFOR | X4 PHARMACEUTICALS INC | 357K | $1M+ | SH |
| EWTX | EDGEWISE THERAPEUTICS INC | 42K | $1M+ | SH |
| RADX | RADIOPHARM THERANOSTICS LTD | 187K | $500K+ | SH |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 100K | $500K+ | SH |
| ADGM | ADAGIO MED HLDGS INC | 515K | $500K+ | SH |
| RAPP | RAPPORT THERAPEUTICS INC | 10K | $100K–$500K | SH |
| PALI | PALISADE BIO INC | 102K | $100K–$500K | SH |
| IBIO | IBIO INC | 106K | $100K–$500K | SH |
| RCKTW | ROCKET PHARMACEUTICALS INC | 105K | $1K–$15K | SH |